vs
ICU MEDICAL INC（ICUI）与SunCoke Energy, Inc.（SXC）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是SunCoke Energy, Inc.的1.1倍（$540.7M vs $480.2M），ICU MEDICAL INC净利率更高（-2.9% vs -17.8%，领先14.9%），SunCoke Energy, Inc.同比增速更快（-1.2% vs -14.1%），ICU MEDICAL INC自由现金流更多（$36.0M vs $32.8M），过去两年SunCoke Energy, Inc.的营收复合增速更高（-0.8% vs -2.3%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
Energy Brands（又称Glacéau）是可口可乐公司旗下的私有子公司，总部位于纽约皇后区白石镇，主要生产并销售多款宣传为强化水的饮品。该公司由J·达里厄斯·比科夫创立于1996年5月，最初以电解质强化水品牌Smartwater起家，产品仅在纽约地区的健康食品店与独立零售商销售，后续逐步推出Fruitwater、Vitaminwater等产品线。
ICUI vs SXC — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $480.2M |
| 净利润 | $-15.7M | $-85.6M |
| 毛利率 | 37.5% | — |
| 营业利润率 | 1.0% | -20.4% |
| 净利率 | -2.9% | -17.8% |
| 营收同比 | -14.1% | -1.2% |
| 净利润同比 | 34.0% | -461.2% |
| 每股收益（稀释后） | $-0.63 | $-1.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $540.7M | $480.2M | ||
| Q3 25 | $537.0M | $487.0M | ||
| Q2 25 | $548.9M | $434.1M | ||
| Q1 25 | $604.7M | $436.0M | ||
| Q4 24 | $629.8M | $486.0M | ||
| Q3 24 | $589.1M | $490.1M | ||
| Q2 24 | $596.5M | $470.9M | ||
| Q1 24 | $566.7M | $488.4M |
| Q4 25 | $-15.7M | $-85.6M | ||
| Q3 25 | $-3.4M | $22.2M | ||
| Q2 25 | $35.3M | $1.9M | ||
| Q1 25 | $-15.5M | $17.3M | ||
| Q4 24 | $-23.8M | $23.7M | ||
| Q3 24 | $-33.0M | $30.7M | ||
| Q2 24 | $-21.4M | $21.5M | ||
| Q1 24 | $-39.5M | $20.0M |
| Q4 25 | 37.5% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 37.9% | — | ||
| Q1 25 | 34.7% | — | ||
| Q4 24 | 36.1% | — | ||
| Q3 24 | 34.8% | — | ||
| Q2 24 | 34.8% | — | ||
| Q1 24 | 32.7% | — |
| Q4 25 | 1.0% | -20.4% | ||
| Q3 25 | 2.6% | 2.8% | ||
| Q2 25 | 1.9% | 2.3% | ||
| Q1 25 | 2.1% | 6.9% | ||
| Q4 24 | 6.0% | 7.3% | ||
| Q3 24 | 1.4% | 9.6% | ||
| Q2 24 | 1.3% | 7.4% | ||
| Q1 24 | -1.9% | 7.1% |
| Q4 25 | -2.9% | -17.8% | ||
| Q3 25 | -0.6% | 4.6% | ||
| Q2 25 | 6.4% | 0.4% | ||
| Q1 25 | -2.6% | 4.0% | ||
| Q4 24 | -3.8% | 4.9% | ||
| Q3 24 | -5.6% | 6.3% | ||
| Q2 24 | -3.6% | 4.6% | ||
| Q1 24 | -7.0% | 4.1% |
| Q4 25 | $-0.63 | $-1.00 | ||
| Q3 25 | $-0.14 | $0.26 | ||
| Q2 25 | $1.43 | $0.02 | ||
| Q1 25 | $-0.63 | $0.20 | ||
| Q4 24 | $-0.97 | $0.28 | ||
| Q3 24 | $-1.35 | $0.36 | ||
| Q2 24 | $-0.88 | $0.25 | ||
| Q1 24 | $-1.63 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $88.7M |
| 总债务越低越好 | — | $685.5M |
| 股东权益账面价值 | $2.1B | $597.3M |
| 总资产 | $4.1B | $1.8B |
| 负债/权益比越低杠杆越低 | — | 1.15× |
8季度趋势，按日历期对齐
| Q4 25 | — | $88.7M | ||
| Q3 25 | — | $80.4M | ||
| Q2 25 | — | $186.2M | ||
| Q1 25 | — | $193.7M | ||
| Q4 24 | $308.6M | $189.6M | ||
| Q3 24 | $312.5M | $164.7M | ||
| Q2 24 | $302.6M | $81.9M | ||
| Q1 24 | $251.4M | $120.1M |
| Q4 25 | — | $685.5M | ||
| Q3 25 | — | $691.1M | ||
| Q2 25 | — | $493.4M | ||
| Q1 25 | — | $492.9M | ||
| Q4 24 | — | $492.3M | ||
| Q3 24 | — | $491.8M | ||
| Q2 24 | — | $491.3M | ||
| Q1 24 | — | $490.8M |
| Q4 25 | $2.1B | $597.3M | ||
| Q3 25 | $2.1B | $695.9M | ||
| Q2 25 | $2.1B | $677.7M | ||
| Q1 25 | $2.0B | $684.6M | ||
| Q4 24 | $2.0B | $680.2M | ||
| Q3 24 | $2.0B | $658.6M | ||
| Q2 24 | $2.0B | $636.9M | ||
| Q1 24 | $2.1B | $623.0M |
| Q4 25 | $4.1B | $1.8B | ||
| Q3 25 | $4.1B | $1.9B | ||
| Q2 25 | $4.1B | $1.6B | ||
| Q1 25 | $4.2B | $1.7B | ||
| Q4 24 | $4.2B | $1.7B | ||
| Q3 24 | $4.3B | $1.7B | ||
| Q2 24 | $4.3B | $1.7B | ||
| Q1 24 | $4.3B | $1.7B |
| Q4 25 | — | 1.15× | ||
| Q3 25 | — | 0.99× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 0.72× | ||
| Q4 24 | — | 0.72× | ||
| Q3 24 | — | 0.75× | ||
| Q2 24 | — | 0.77× | ||
| Q1 24 | — | 0.79× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $56.6M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $32.8M |
| 自由现金流率自由现金流/营收 | 6.6% | 6.8% |
| 资本支出强度资本支出/营收 | 4.6% | 5.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $91.8M | $42.3M |
8季度趋势，按日历期对齐
| Q4 25 | $60.6M | $56.6M | ||
| Q3 25 | $56.7M | $9.2M | ||
| Q2 25 | $11.2M | $17.5M | ||
| Q1 25 | $51.3M | $25.8M | ||
| Q4 24 | $40.2M | $60.9M | ||
| Q3 24 | $36.1M | $107.2M | ||
| Q2 24 | $82.0M | $-9.3M | ||
| Q1 24 | $45.8M | $10.0M |
| Q4 25 | $36.0M | $32.8M | ||
| Q3 25 | $27.6M | $-16.3M | ||
| Q2 25 | $-8.5M | $4.9M | ||
| Q1 25 | $36.7M | $20.9M | ||
| Q4 24 | $16.1M | $36.1M | ||
| Q3 24 | $16.2M | $92.1M | ||
| Q2 24 | $62.5M | $-26.8M | ||
| Q1 24 | $29.9M | $-5.5M |
| Q4 25 | 6.6% | 6.8% | ||
| Q3 25 | 5.1% | -3.3% | ||
| Q2 25 | -1.5% | 1.1% | ||
| Q1 25 | 6.1% | 4.8% | ||
| Q4 24 | 2.6% | 7.4% | ||
| Q3 24 | 2.7% | 18.8% | ||
| Q2 24 | 10.5% | -5.7% | ||
| Q1 24 | 5.3% | -1.1% |
| Q4 25 | 4.6% | 5.0% | ||
| Q3 25 | 5.4% | 5.2% | ||
| Q2 25 | 3.6% | 2.9% | ||
| Q1 25 | 2.4% | 1.1% | ||
| Q4 24 | 3.8% | 5.1% | ||
| Q3 24 | 3.4% | 3.1% | ||
| Q2 24 | 3.3% | 3.7% | ||
| Q1 24 | 2.8% | 3.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.41× | ||
| Q2 25 | 0.32× | 9.21× | ||
| Q1 25 | — | 1.49× | ||
| Q4 24 | — | 2.57× | ||
| Q3 24 | — | 3.49× | ||
| Q2 24 | — | -0.43× | ||
| Q1 24 | — | 0.50× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
SXC
暂无分部数据
